Diffuse alveolar hemorrhage following itraconazole injection

Internal Medicine

Volumn 49, Issue 5, 2010, Pages 497-500

  Izumikawa, Koichi ^a   Nakano, Ken ^a   Kurihara, Shintaro ^a   Imamura, Yoshifumi ^a   Yamamoto, Kazuko ^a   Miyazaki, Taiga ^a   Sakamoto, Noriho ^a   Seki, Masafumi ^a   Ishimatsu, Yuji ^a   Kakeya, Hiroshi ^a   Yamamoto, Yoshihiro ^a   Yanagihara, Katsunori ^a   Tsuchiya, Tomoshi ^a   Yamasaki, Naoya ^a   Tagawa, Tsutomu ^a   Mukae, Hiroshi ^a   Nagayasu, Takeshi ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diffuse alveolar hemorrhage; Intravenous itraconazole; PMX

Indexed keywords

CIPROFLOXACIN; ITRACONAZOLE; METHYLPREDNISOLONE; POLYMYXIN B; SIVELESTAT; SULTAMICILLIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS FUMIGATUS; CASE REPORT; DIFFUSE LUNG HEMORRHAGE; DRUG PULSE THERAPY; HEMOPERFUSION; HUMAN; LUNG ASPERGILLOSIS; LUNG HEMORRHAGE; LUNG LAVAGE; LUNG RESECTION; LYMPHOCYTE TRANSFORMATION TEST; MALE; PLEURA EFFUSION; POSTOPERATIVE PERIOD;

ANTIFUNGAL AGENTS; CHRONIC DISEASE; HEMOPERFUSION; HEMORRHAGE; HUMANS; INJECTIONS, INTRAVENOUS; ITRACONAZOLE; LUNG DISEASES; MALE; MIDDLE AGED; POLYMYXIN B; PULMONARY ASPERGILLOSIS;

EID: 77949301507     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2735     Document Type: Article

References (14)

1. Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Clin Chest Med 25: 583-592, vii, 2004.
2. Fontenot AP, Schwarz MI. Diffuse alveolar hemorrhage. In: Interstitial Lung Disease. 4th ed. King TE Jr, Schwarz MI, Eds. BC Decker, Hamilton, 2003: 632.
3. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46: 327-360, 2008.
4. Ahmad SR, Singer SJ, Leissa BG. Congestive heart failure associated with itraconazole. Lancet 357: 1766-1767, 2001.
5. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59: 809-820, 2004.
6. Beeler A, Pichler WJ. In vitro tests of T-cell-mediated drug hypersensitivity. In: Drug Hypersensitivity. Karger AG, Basel, 2007: 380-390.
7. Kano Y, Hirahara K, Mitsuyama Y, Takahashi R, Shiohara T. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 62: 1439-1444, 2007.
8. Luque I, Leyva L, Jose Torres M, et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 56: 611-618, 2001.
9. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 27: 175-181, 1997.
10. Warrington RJ, McPhilips-Feener S, Rutherford WJ. The predictive value of the lymphocyte transformation test in isoniazid-associated hepatitis. Clin Allergy 12: 217-222, 1987.
11. Madore F, Lazarus JM, Brady HR. Therapeutic plasma exchange in renal diseases. J Am Soc Nephrol 7: 367-386, 1996.
12. Takazono T, Izumikawa K, Tsurutani J, et al. Lemierre's syndrome followed by acute respiratory distress syndrome successfully rescued by antibiotics and hemoperfusion with polymyxin B-immobilized fiber. Jpn J Infect Dis 62: 133-136, 2009.
13. Cruz DN, Perazella MA, Bellomo R, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 11: R47, 2007.
14. Tsushima K, Kubo K, Yoshikawa S, et al. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome. Ther Apher Dial 11: 138-145, 2007.